NorthCrest Asset Manangement’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
NorthCrest Asset Manangement's PFE Position: Q2 2026 in Review
NorthCrest Asset Manangement increased its Pfizer (PFE) stake by 27% in Q2 2026, buying an estimated $323K and bringing the position to 58,166 shares worth $1.41M. The position accounts for 0.04% of the portfolio, ranked #298.
NorthCrest Asset Manangement first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $21.5M in Q2 2022. 1,284 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- NorthCrest Asset Manangement held 58,166 shares of Pfizer worth $1.41M as of Q2 2026.
- NorthCrest Asset Manangement bought 12,360 Pfizer shares in Q2 2026, an estimated $323K.
- Pfizer made up 0.04% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #298 holding.
- NorthCrest Asset Manangement first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- NorthCrest Asset Manangement's Pfizer position peaked at $21.5M in Q2 2022.
- 1,284 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.